IL143488A0 - Cancer treatment composition and method using natural plant essential oils - Google Patents

Cancer treatment composition and method using natural plant essential oils

Info

Publication number
IL143488A0
IL143488A0 IL14348899A IL14348899A IL143488A0 IL 143488 A0 IL143488 A0 IL 143488A0 IL 14348899 A IL14348899 A IL 14348899A IL 14348899 A IL14348899 A IL 14348899A IL 143488 A0 IL143488 A0 IL 143488A0
Authority
IL
Israel
Prior art keywords
treatment composition
cancer treatment
essential oils
natural plant
plant essential
Prior art date
Application number
IL14348899A
Other languages
English (en)
Original Assignee
Ecosmart Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ecosmart Technologies Inc filed Critical Ecosmart Technologies Inc
Publication of IL143488A0 publication Critical patent/IL143488A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL14348899A 1998-12-07 1999-12-07 Cancer treatment composition and method using natural plant essential oils IL143488A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11127198P 1998-12-07 1998-12-07
PCT/US1999/028888 WO2000033857A1 (en) 1998-12-07 1999-12-07 Cancer treatment composition and method using natural plant essential oils

Publications (1)

Publication Number Publication Date
IL143488A0 true IL143488A0 (en) 2002-04-21

Family

ID=22337523

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14348899A IL143488A0 (en) 1998-12-07 1999-12-07 Cancer treatment composition and method using natural plant essential oils

Country Status (24)

Country Link
US (8) US20020182268A1 (es)
EP (3) EP1137425A1 (es)
JP (3) JP2002531511A (es)
KR (1) KR20010080692A (es)
CN (1) CN100448454C (es)
AR (3) AR020020A1 (es)
AT (1) ATE307601T1 (es)
AU (3) AU2167100A (es)
BR (1) BR9916879A (es)
CA (3) CA2353475A1 (es)
CZ (1) CZ20011979A3 (es)
DE (1) DE69928000T2 (es)
ES (1) ES2247858T3 (es)
HU (1) HUP0104674A3 (es)
ID (1) ID29393A (es)
IL (1) IL143488A0 (es)
MX (3) MXPA01005641A (es)
NO (1) NO20012774L (es)
NZ (1) NZ527850A (es)
PL (1) PL349028A1 (es)
RU (1) RU2252772C2 (es)
TR (1) TR200101481T2 (es)
WO (3) WO2000033857A1 (es)
ZA (1) ZA200104611B (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002531511A (ja) * 1998-12-07 2002-09-24 エコスマート テクノロジーズ，インコーポレーテッド シグナル伝達調節物質と天然植物精油を用いた癌治療薬配合物および方法
DE10113513A1 (de) * 2001-03-20 2002-10-02 Medinnova Ges Med Innovationen Kombinationspräparat zur Prophylaxe und/oder Therapie von Nervenzell- und/oder Gliazellschäden durch ein neues Behandlungsverfahren
US7186735B2 (en) * 2002-08-07 2007-03-06 Sanofi-Aventis Deutschland Gmbh Acylated arylcycloalkylamines and their use as pharmaceuticals
CN101703080A (zh) * 2002-08-12 2010-05-12 隆萨股份有限公司 抗菌组合物
CA2407755A1 (en) * 2002-10-11 2004-04-11 The Hospital For Sick Children Inhibition of vegf secretion
DE10259619A1 (de) * 2002-12-18 2004-07-08 Metagen Pharmaceuticals Gmbh Verwendung einer TRPM8 aktivierenden Substanz zur Tumorbehandlung
MD2231C2 (ro) * 2003-03-05 2004-02-29 Ион КАЛМЫК Compozitie pentru tratamentul patologiilor oncologice
OA13160A (en) * 2003-04-24 2006-12-13 Univ Vanderbilt Compositions and methods for controlling insects.
US7622269B2 (en) * 2004-03-19 2009-11-24 Tyratech, Inc. Methods of screening tyramine- and octopamine-expressing cells for compounds and compositions having potential insect control activity
US20060263403A1 (en) * 2003-04-24 2006-11-23 Essam Enan Compositions and methods for controlling insects involving the tyramine receptor
US7893072B2 (en) 2003-07-02 2011-02-22 Genentech, Inc. Trp-p8 active compounds and therapeutic treatment methods
DE10341933A1 (de) * 2003-09-11 2005-04-14 Lts Lohmann Therapie-Systeme Ag Medizinische Hautpflaster mit einem Gehalt an ätherischen Ölen zur Behandlung von Erkältungskrankheiten, sowie Verfahren für deren Herstellung
SE0401302D0 (sv) * 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Inhibition of erk-phosphorylation
WO2006120495A1 (fr) * 2005-05-13 2006-11-16 Advanced Scientific Developements Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol
WO2006134609A2 (en) * 2005-06-16 2006-12-21 Mmi Corporation Novel anticancer agent, methods for obtaining the same and pharmaceutical compositions thereof
CN100553628C (zh) 2005-08-25 2009-10-28 中国人民解放军军事医学科学院放射与辐射医学研究所 2-溴-异香兰素在制备抗癌和/或辐射、化疗增敏药物中的应用
MX2008016453A (es) 2006-06-27 2009-05-15 Tyratech Inc Composiciones y metodos para tratar infecciones parasitas.
EP2048944A4 (en) * 2006-07-17 2012-06-27 Tyratech Inc COMPOSITIONS AND METHODS FOR CONTROLLING INSECTS
BRPI0806666A8 (pt) * 2007-01-16 2018-02-06 Tyratech Inc Composições e método para controle de praga
JP2011021013A (ja) * 2009-06-19 2011-02-03 Ube Industries Ltd オキシル基を有する芳香族メチルアルコール化合物の製造方法
WO2011036048A1 (en) 2009-09-24 2011-03-31 Unilever Nv Disinfecting agent comprising eugenol, terpineol and thymol
US8003393B1 (en) * 2010-02-09 2011-08-23 Panasonic Corporation Method for determining whether or not a mammal is affected with a lung cancer
WO2012006563A2 (en) * 2010-07-08 2012-01-12 The Administrators Of The Tulane Educational Fund Novel daidzein analogs as treatment for cancer
FR2967055B1 (fr) * 2010-11-08 2012-12-21 Biochimie Appliquee Solabia Compositions cosmetiques a base d'esters de piperonyle et leur utilisation en sosmetique en tant qu'anti-vieillissement cutane et agent depigmentant
BR112013013085B1 (pt) 2010-12-07 2018-02-14 Unilever N.V. Composição de cuidados orais, enxaguante bucal, creme dental, dentífrico, método para desinfetar a cavidade oral e uso de uma composição
WO2012104568A1 (en) * 2011-02-02 2012-08-09 GILHOLM, Stephen Philip Compositions of monoterpenoids for stimulating the immune system
WO2012177799A1 (en) * 2011-06-20 2012-12-27 Atheronova Operations, Inc. Subcutaneous fat reduction
WO2013064360A2 (en) 2011-11-03 2013-05-10 Unilever N.V. A personal cleaning composition
KR101357395B1 (ko) 2012-08-06 2014-02-05 영남대학교 산학협력단 신규한 테트라졸로 하이드라존 유도체 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학 조성물
US9950071B2 (en) * 2014-01-03 2018-04-24 Industrial Cooperation Foundation Chonbuk National University Hybrid anticancer prodrug simultaneously producing cinnamaldehyde and quinone methide and method for preparing same
WO2015102448A1 (ko) * 2014-01-03 2015-07-09 전북대학교 산학협력단 신남알데히드 및 퀴논 메티드를 동시에 생성하는 혼성 항암 전구약물 및 이의 제조방법
JP6669665B2 (ja) * 2014-03-20 2020-03-18 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 体重管理にシンナムアルデヒド及び亜鉛を用いるための方法及び組成物
US9402834B2 (en) 2014-10-21 2016-08-02 Ions Pharmaceutical S.À R.L. Human therapeutic agents
US10092550B2 (en) 2014-10-21 2018-10-09 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof
US9907786B2 (en) 2014-10-21 2018-03-06 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof
DE102015119552B4 (de) * 2015-10-23 2022-06-15 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Monoterpenhaltige Zusammensetzung zur Behandlung von Tumor- und/oder Krebserkrankungen
CN105294465A (zh) * 2015-12-08 2016-02-03 天津医科大学 一种抗乳腺癌转移作用的手性紫罗兰酮生物碱衍生物及医药用途
CN105559074B (zh) * 2016-02-03 2019-02-12 华南农业大学 一种茶叶挥发性精油在制备防癌保健品或抗癌药物中的应用
KR101798203B1 (ko) * 2016-09-23 2017-11-15 전북대학교 산학협력단 산성 pH 및 에스테라아제에 의해 신남알데히드 및 퀴논메티드를 동시에 생성하는 혼성 항암 전구약물 및 이의 제조방법
EP3773502A4 (en) 2018-04-06 2022-05-18 UCAR Health GmbH TREATMENT OF CANCER BY GUANIDINIUM DERIVATIVES
CN109112106B (zh) * 2018-09-07 2022-01-04 广州长峰生物技术有限公司 人原代肝癌组织的体外模型的建立方法
WO2022069013A1 (fr) * 2020-10-04 2022-04-07 Omar Bencherguia Composition médicamenteuse pour le traitement et la prévention du covid-19 et autres infections et affections nouvelles applications de l'alpha-acetoxytoluène, l'alcool benzylique et les groupes benzyle dans la lutte contre la pandémie covid-19 et autres infections et affections

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261989A (en) * 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
JPS57106697A (en) * 1980-12-22 1982-07-02 Kyowa Hakko Kogyo Co Ltd Easily absorbable map composition and preparation containing the same
US4751224A (en) * 1983-07-21 1988-06-14 Brown University Research Foundation Treatment of metastasis
FR2557452B1 (fr) * 1983-12-28 1986-08-14 Roussel Uclaf Nouvelles compositions pour les soins de la peau renfermant de l'huile d'onagre et des traits tissulaires de rate
DE3515253C1 (de) * 1985-04-27 1986-06-19 Werner 6780 Pirmasens Walter Verwendung von isopropanolischen Lösungen von Diphenyl als topisches Arzneimittel
DE3634697A1 (de) * 1986-10-11 1988-04-21 Dentaire Ivoclar Ets Dentalwerkstoff zur bekaempfung von karies und parodontose
DE3826846A1 (de) * 1988-08-06 1990-02-08 Goedecke Ag Alkoxy-4(1h)-pyridon-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE3829200A1 (de) * 1988-08-29 1990-03-01 Kaempgen Dieter Dr Phil Wirkstoffe gegen die immunschwaeche-krankheit aids
JP2746453B2 (ja) * 1990-03-13 1998-05-06 鐘紡株式会社 活性酸素消去剤
EP0448029B1 (en) 1990-03-23 1995-12-20 Nippon Kayaku Kabushiki Kaisha Novel pharmaceutical uses of forskolin derivatives
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
FR2683454B1 (fr) 1991-11-13 1995-06-09 Pf Medicament Composition pharmaceutique bactericide.
DK0663831T3 (da) * 1991-12-13 1995-07-26 Searle & Co Transdermal azidothymidin
EP0567948B1 (en) * 1992-04-29 1996-09-11 NORDICA S.p.A Braking device on a roller skate
PT656786E (pt) * 1992-05-19 2004-11-30 Novogen Res Pty Ltd Utilizacao de extractos do fitoestrogenio isoflavona de soja ou trevo
FR2697133B1 (fr) * 1992-10-28 1995-01-13 Transbiotech Composition biocide et/ou biostatique et ses applications.
US5602184A (en) * 1993-03-03 1997-02-11 The United States Of America As Represented By Department Of Health And Human Services Monoterpenes, sesquiterpenes and diterpenes as cancer therapy
US5387584A (en) * 1993-04-07 1995-02-07 Pfizer Inc. Bicyclic ansamycins
JP3263481B2 (ja) 1993-05-19 2002-03-04 三洋電機株式会社 半導体装置および半導体装置の製造方法
FR2706771A1 (en) * 1993-06-21 1994-12-30 Pelletier Jacques Formula for the treatment of certain cancers.
US5595756A (en) 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
US5626854A (en) 1994-03-17 1997-05-06 Kao Corporation Bath composition
US5911995A (en) * 1994-08-19 1999-06-15 Regents Of The University Of Minnesota EGF-genistein conjugates for the treatment of cancer
US5795910A (en) * 1994-10-28 1998-08-18 Cor Therapeutics, Inc. Method and compositions for inhibiting protein kinases
RU2179440C2 (ru) * 1997-03-04 2002-02-20 Висконсин Эламнай Рисерч Фаундэйшн Композиция и способы подавления роста опухолевых клеток и опухоли с ее использованием
AU7165798A (en) 1997-04-28 1998-11-24 Anticancer, Inc. Use of genistein and related compounds to treat certain sex hormone related conditions
JP2001510168A (ja) * 1997-07-18 2001-07-31 ノボ ノルディスク アクティーゼルスカブ ＦＶＩＩａ媒介性細胞内シグナル伝達経路に関連する反対条件の処理のためのＦＶＩＩａ又はＦＶＩＩａｉの使用
JP2001506533A (ja) * 1998-03-20 2001-05-22 ザ、プロクター、エンド、ギャンブル、カンパニー 芳香放出のための組成物
AT407821B (de) * 1998-03-24 2001-06-25 Franz Dr Stueckler Mittel auf der basis von naturstoffen
US6028061A (en) 1998-06-18 2000-02-22 Children's Medical Center Corp Angiogenesis inhibitors and use thereof
EP1123106B1 (de) * 1998-10-23 2003-07-23 Dieter Ebert Zusammensetzung enthaltend eugenol und polyphenole, verwendung einer solchen zusammensetzung zur wundheilung
KR100312622B1 (ko) * 1998-11-03 2002-02-28 김송배 생약을주성분으로한안정화된항암제조성물및그제조방법
JP2002531511A (ja) * 1998-12-07 2002-09-24 エコスマート テクノロジーズ，インコーポレーテッド シグナル伝達調節物質と天然植物精油を用いた癌治療薬配合物および方法
US6147107A (en) * 1998-12-20 2000-11-14 Virginia Commonwealth University Specific inhibition of the P42/44 mitogen activated protein (map) kinase cascade sensitizes tumor cells

Also Published As

Publication number Publication date
US20030017215A1 (en) 2003-01-23
MXPA01005545A (es) 2003-07-14
CA2353516A1 (en) 2000-06-15
WO2000033857A9 (en) 2001-12-13
ZA200104611B (en) 2001-12-13
PL349028A1 (en) 2002-07-01
CA2353476A1 (en) 2000-06-15
WO2000033858A1 (en) 2000-06-15
US7291650B2 (en) 2007-11-06
KR20010080692A (ko) 2001-08-22
CN1329498A (zh) 2002-01-02
CZ20011979A3 (cs) 2001-10-17
EP1137426B1 (en) 2005-10-26
WO2000033856A1 (en) 2000-06-15
US7008649B2 (en) 2006-03-07
TR200101481T2 (tr) 2001-09-21
JP2002531512A (ja) 2002-09-24
EP1137425A1 (en) 2001-10-04
US20080015249A1 (en) 2008-01-17
EP1137426A1 (en) 2001-10-04
AR020021A1 (es) 2002-03-27
NO20012774D0 (no) 2001-06-06
ES2247858T3 (es) 2006-03-01
MXPA01005641A (es) 2003-07-14
AU2167100A (en) 2000-06-26
EP1137427A1 (en) 2001-10-04
WO2000033857A1 (en) 2000-06-15
NO20012774L (no) 2001-06-06
AR020019A1 (es) 2002-03-27
CN100448454C (zh) 2009-01-07
US20030017218A1 (en) 2003-01-23
ID29393A (id) 2001-08-30
NZ527850A (en) 2004-07-30
ATE307601T1 (de) 2005-11-15
AR020020A1 (es) 2002-03-27
BR9916879A (pt) 2001-11-06
MXPA01005598A (es) 2003-07-14
RU2252772C2 (ru) 2005-05-27
US20030108622A1 (en) 2003-06-12
DE69928000T2 (de) 2006-06-08
DE69928000D1 (de) 2005-12-01
JP2002531513A (ja) 2002-09-24
CA2353475A1 (en) 2000-06-15
AU2167000A (en) 2000-06-26
US20030108623A1 (en) 2003-06-12
US20020182268A1 (en) 2002-12-05
US20040156922A1 (en) 2004-08-12
AU1841900A (en) 2000-06-26
US6812258B2 (en) 2004-11-02
HUP0104674A3 (en) 2003-01-28
JP2002531511A (ja) 2002-09-24
HUP0104674A2 (en) 2002-06-29
US20040146595A1 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
IL143488A0 (en) Cancer treatment composition and method using natural plant essential oils
HK1048949A1 (en) Method and composition for the treatment of scars
ZA963844B (en) Seed treatment composition and method
AU6872498A (en) Method and composition for skin treatment
EP0871494A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR CELLS
IL189132A0 (en) Pharmaceutical compositions for the treatment of prostate hypertrophy and prostate cancer
EP0790960A4 (en) METHOD AND SYSTEM FOR TREATING WASTEWATER
PL341799A1 (en) Composition for use in cultivation of plants and method of obtaining such composition
AU5439996A (en) Compositions and methods for treating pain
EP0866683A4 (en) MEANS AND METHOD FOR TREATING DISEASE NAILS
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
IL129742A (en) Method for treating diseased plants
HUP0001629A3 (en) Method for treating plants and copperchelate containing compositions for it
IL124650A0 (en) Methods and therapeutic compositions for treating cancer
IL111554A (en) Methods and compositions for hair treatment
AU3204899A (en) Hair treatment composition and method
EP1089731A4 (en) COMPOSITIONS AND METHOD FOR TREATING INCREASED BLOOD CHOLESTEROL LEVELS
GB9904765D0 (en) Plant treatment method
ZA961637B (en) Methods and compositions for enhancing formyltetrahydropteroylpolyglutamate in plants
HUP0300043A3 (en) Method and composition for the treatment of pain
AU5097099A (en) Methods and compositions for cancer treatment
AU5169200A (en) Methods and compositions for treating breakthrough pain
EP1089732A4 (en) COMPOSITIONS AND METHODS FOR TREATING INCREASED BLOOD CHOLESTEROL LEVELS
ZA987010B (en) Plant and seed treatment method and composition therefor
AU9043098A (en) Plant and seed treatment method and composition therefor